Sage Therapeutics to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
October 25 2022 - 6:30AM
Business Wire
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical
company leading the way to create a world with better brain health,
announced today that it will host a live webcast on Tuesday,
November 8, 2022 at 8:00 a.m. ET to review third quarter 2022
financial results and discuss recent business updates.
The webcast can be accessed on the Investor page of Sage’s
website at investor.sagerx.com. A replay of the webcast will be
available following the completion of the event and will be
archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly
leading the way to create a world with better brain health. Our
mission is to pioneer solutions to deliver life-changing brain
health medicines, so every person can thrive. For more information,
please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221025005315/en/
Investors Helen Rubinstein 315-382-3979
helen.rubinstein@sagerx.com
Media Matthew Henson 917-930-7147
matthew.henson@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2023 to Sep 2024